文献速递其他结缔组织病

系统性硬化症表型与种族相关:个体化医疗的契机

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-06-01

基于加拿大硬皮病研究组队列1477例患者,按自我认同的单一族裔分组比较基线特征与生存。白人族裔弥漫性皮肤型SSc和毛细血管扩张患病率较低;黑人族裔肌炎患病率更高、改良Rodnan皮肤评分更高、肺功能更差且1年与5年生存率最低;原住民抗RNA聚合酶III抗体阳性率最高且下消化道受累更常见。族裔与不同SSc表型相关,可为筛查和管理提供预后信息。

要点

  • 白人族裔弥漫性皮肤型SSc和毛细血管扩张患病率低于其他族裔。
  • 黑人族裔肌炎更常见、皮肤评分更高、肺功能更差且生存率最低。
  • 原住民抗RNA聚合酶III抗体阳性率最高,下消化道受累更常见。

核心结论

  • 族裔与系统性硬化症的不同临床和血清学表型相关,这些差异可提供预后信息并指导筛查和管理策略。

研究设计与样本

  • 纳入加拿大硬皮病研究组队列中自我认同为单一族裔的参与者,比较基线特征并采用Kaplan-Meier曲线和Cox回归估计死亡率。

主要发现

  • 1477例合格参与者中1345例(91.1%)为白人族裔,55例(3.7%)为原住民,22例(1.5%)为东亚/东南亚裔,20例(1.4%)为中东裔,16例(1.1%)为黑人族裔,12例(0.8%)为南亚裔,7例(0.5%)为拉丁美洲裔。
  • 白人族裔弥漫性皮肤型SSc患病率为33%而非白人族裔为53%,毛细血管扩张患病率为44%而非白人族裔为67%。
  • 黑人族裔肌炎患病率为44%而非黑人族裔为10%,平均改良Rodnan皮肤评分为18.4而非黑人族裔为9.6。
  • 黑人族裔平均用力肺活量为预测值的73.7%而非黑人族裔为92.9%,DLco为预测值的54.5%而非黑人族裔为70.6%,1年生存概率为85%、5年生存概率为57%且为最低。
  • 原住民抗RNA聚合酶III抗体阳性率为34%而非原住民为19%,下消化道表现更常见;东亚/东南亚裔雷诺现象(90%)和指端溃疡(29%)受累频率最低。

临床怎么用

  • 临床评估SSc患者时应考虑族裔背景相关的表型差异,以辅助筛查和个体化管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective is to describe and compare demographic, clinical, and serological characteristics of patients with systemic sclerosis (SSc) according to ethnic background. METHODS: Participants enrolled in the Canadian Scleroderma Research Group cohort who self-identified to a single ethnicity group were included. Baseline characteristics were compared using analysis of variance, chi-square, or Kruskal-Wallis rank sum test. Kaplan-Meier curves and Cox regression were used to estimate mortality. RESULTS: Of 1,477 eligible participants, 1,345 (91.1%) identified as White, 55 (3.7%) as Indigenous, 22 (1.5%) as East/Southeast Asian, 20 (1.4%) as Middle Eastern, 16 (1.1%) as Black, 12 (0.8%) as South Asian, and 7 (0.5%) as Latin American. White individuals had a lower prevalence of diffuse cutaneous SSc (33% vs 53%) and telangiectasias (44% vs 67%) compared with other ethnicities. Conversely, Black individuals had a higher prevalence of myositis (44% vs 10%), higher mean modified Rodnan skin score (18.4 vs 9.6), lower mean forced vital capacity (73.7% predicted vs 92.9% predicted) and DLco values (54.5% predicted vs 70.6% predicted), and the lowest survival probabilities at one (85%) and five years (57%). Indigenous individuals had the highest prevalence of anti-RNA polymerase III antibodies (34% vs 19%) and were more frequently affected by lower gastrointestinal manifestations. East/Southeast Asian individuals were the least frequently affected by Raynaud phenomenon (90%) and digital ulcers (29%). CONCLUSION: Ethnicity was associated with distinct SSc phenotypes. These differences provide prognostic information that can guide screening and management strategies, thus representing an opportunity to personalize care.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Goulet D, Guertin C, Larché M, et al. Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care? Arthritis Care Res (Hoboken). 2026. PMID: 42223235. doi:10.1002/acr.80098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。